Piero Fregatti1,2, Marco Gipponi3, Maria Giacchino1, Marco Sparavigna1, Raquel Diaz2, Emanuela Fioravanti1, Chiara Cornacchia1, Benedetta Conte4,5, Matteo Lambertini4,5, Gabriele Zoppoli4,6, Federica Murelli1,2, Maria Luisa Toni7, Maria Teresa Calabro1, Lina Orsino7, Daniele Friedman1,2. 1. Department of Surgical Sciences and Integrated Diagnostic (DISC), School of Medicine, University of Genoa, Genoa, Italy. 2. Breast Surgery Clinic, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. 3. Breast Surgery Clinic, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; marco.gipponi@hsanmartino.it. 4. Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genoa, Genoa, Italy. 5. Department of Medical Oncology, U.O.C Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. 6. Internal Medicine and Oncology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. 7. Direction Health Professions (DAPS), IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Abstract
BACKGROUND/AIM: The perspective validation of a selective approach in patients undergoing breast cancer surgery was performed in order to assess whether patients as well as Health Care Workers (HCWs) were exposed to any undue risk of COVD-19 infection. PATIENTS AND METHODS: From March 9th to June 9th 2020, 207 patients were phone-triaged by a dedicated Breast Care Nurse; a patient-tailored program was adopted with the aim of avoiding hospitalization of SARS-CoV-2 symptomatic patients, with a careful prioritization of surgical procedures according to specific disease features. RESULTS: Two hundred and three out of 207 patients underwent operation; seven patients were temporarily excluded because they tested positive at phone triage (n=3), or in-hospital triage (n=3); another asymptomatic patient with negative NP swab tested IgM Ab-positive so that surgery was re-scheduled two weeks later. Four patients had no surgery; one of them was reconsidered for neoadjuvant chemotherapy (NAC) after testing positive at phone triage; three patients were excluded because they were already hospitalized for COVID-19. Overall, mean in-hospital stay was 2.2 days (±SD, 0.7) and, after hospital discharge, no patient required readmission. CONCLUSION: This preventive program avoided any COVID-19 infection among patients and HCWs, so that an elective breast cancer surgical procedure can be safely and timely pursued without affecting the oncologic outcome. Copyright
BACKGROUND/AIM: The perspective validation of a selective approach in patients undergoing breast cancer surgery was performed in order to assess whether patients as well as Health Care Workers (HCWs) were exposed to any undue risk of COVD-19 infection. PATIENTS AND METHODS: From March 9th to June 9th 2020, 207 patients were phone-triaged by a dedicated Breast Care Nurse; a patient-tailored program was adopted with the aim of avoiding hospitalization of SARS-CoV-2 symptomatic patients, with a careful prioritization of surgical procedures according to specific disease features. RESULTS: Two hundred and three out of 207 patients underwent operation; seven patients were temporarily excluded because they tested positive at phone triage (n=3), or in-hospital triage (n=3); another asymptomatic patient with negative NP swab tested IgM Ab-positive so that surgery was re-scheduled two weeks later. Four patients had no surgery; one of them was reconsidered for neoadjuvant chemotherapy (NAC) after testing positive at phone triage; three patients were excluded because they were already hospitalized for COVID-19. Overall, mean in-hospital stay was 2.2 days (±SD, 0.7) and, after hospital discharge, no patient required readmission. CONCLUSION: This preventive program avoided any COVID-19 infection among patients and HCWs, so that an elective breast cancer surgical procedure can be safely and timely pursued without affecting the oncologic outcome. Copyright
Authors: Gianluca Vanni; Marco Materazzo; Marco Pellicciaro; Sara Ingallinella; Maurizio Rho; Francesca Santori; Maria Cotesta; Jonathan Caspi; Anna Makarova; Chiara Adriana Pistolese; Oreste Claudio Buonomo Journal: In Vivo Date: 2020-06 Impact factor: 2.155
Authors: Piero Fregatti; Marco Gipponi; Maria Giacchino; Marco Sparavigna; Federica Murelli; Maria Luisa Toni; Maria Teresa Calabrò; Lina Orsino; Daniele Friedman Journal: In Vivo Date: 2020-06 Impact factor: 2.155